100 Days Into the Job, FDA Head Talks to CNN About Agency Goals— and Coke’s Switch to Sugar
UNITED STATES, JUL 24 – Coca-Cola will sell a pricier cane sugar Coke as a supplemental product following political pressure despite experts saying sugar type change won’t reduce health risks.
- On Tuesday, Coca-Cola announced a cane sugar–sweetened Coke for the U.S. this fall, following pressure from President Donald Trump and Robert F. Kennedy Jr.
- Last year, America imported $2.5 billion in sugar but exported just $379 million, and Robert F. Kennedy Jr. said high-fructose corn syrup `is just a formula for making you obese and diabetic`.
- According to specialists, all added sugar raises blood glucose equally, expert Marie-Pierre St-Onge said.
- The market reaction was swift as Archer-Daniels-Midland and Ingredion shares slid, with 6% and 7% declines respectively.
- Supply chain analysts caution about pricier imports, Bloomberg warns of potential supply-chain strain, and the U.S. may need to import more expensive sweetener from Mexico and Brazil.
19 Articles
19 Articles


Coca-Cola gradually replaces corn syrup with cane sugar in the USA. The change seems to follow the pressure of Donald Trump – who had repeatedly spoken out for "real sugar". But the change is controversial.


Coca-Cola’s cane sugar comeback could sweeten the future for Louisiana farmers
Donaldsonville, La. (Louisiana First) — A major move from one of the world’s most iconic brands could mean big business for Louisiana’s sugarcane industry. Coca-Cola recently announced a return to cane sugar in some of its product lines—a shift away from high-fructose corn syrup that has farmers across Louisiana buzzing with optimism. Among them is Ross Noel, a fourth-generation sugarcane farmer in Donaldsonville. For Noel, sugarcane is his fami…
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
White Oak, Md. (CNN) — The US Food and Drug Administration is plowing ahead with sweeping plans to crack down on ultra processed foods and reshape the way new drugs and devices are reviewed and approved, the agency’s commissioner, Marty…
Coverage Details
Bias Distribution
- 71% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium